Vitalis is a transnational pharmaceutical company specializing in the manufacturing and commercialization of injectable medicines. With a workforce of over 1,500 employees and 7 production plants across Colombia, Mexico, and Chile, the company is certified in Good Manufacturing Practices. Operating in 20 countries across Latin America and Asia, Vitalis has received global recognition for its pioneering work in implementing secure drug identification strategies to prevent medication errors during storage, dispensing, and administration.
For its commitment to patient safety, Vitalis was honored with the George DiDomizio Award by the Institute for Safe Medication Practices (ISMP), a renowned international organization focused on enhancing medication safety. As a result, Vitalis has established itself as a leader in generating guidelines to improve the safe use of medicines. Founded in 1978, Vitalis has made significant strides in the Health Care and Pharmaceutical industries, solidifying its position as an innovative and impactful player in the global healthcare landscape.
There is no investment information